| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the management of HER2-positive early breast cancer
|
Baselga, José
|
|
2017
|
119 |
C |
p. 113-122
10 p.
|
artikel
|
| 2 |
Clinical pharmacology of anti-angiogenic drugs in oncology
|
Gougis, P.
|
|
2017
|
119 |
C |
p. 75-93
19 p.
|
artikel
|
| 3 |
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?
|
Attili, Ilaria
|
|
2017
|
119 |
C |
p. 30-39
10 p.
|
artikel
|
| 4 |
Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology
|
Sanfrancesco, Joseph M.
|
|
2017
|
119 |
C |
p. 23-28
6 p.
|
artikel
|
| 5 |
Corrigendum to “The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity” [Crit. Rev. Oncol./Hematol. 116 (2017) 82–88]
|
Bossi, Paolo
|
|
2017
|
119 |
C |
p. 29-
1 p.
|
artikel
|
| 6 |
Critical risk-benefit assessment of the novel anti-cancer aurora a kinase inhibitor alisertib (MLN8237): A comprehensive review of the clinical data
|
Tayyar, Yaman
|
|
2017
|
119 |
C |
p. 59-65
7 p.
|
artikel
|
| 7 |
Developing drugs in cancer-related bone pain
|
Lucchesi, Maurizio
|
|
2017
|
119 |
C |
p. 66-74
9 p.
|
artikel
|
| 8 |
Do alcoholic beverages, obesity and other nutritional factors modify the risk of familial colorectal cancer? A systematic review
|
Fardet, Anthony
|
|
2017
|
119 |
C |
p. 94-112
19 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2017
|
119 |
C |
p. IFC-
1 p.
|
artikel
|
| 10 |
Genistein: Its role in metabolic diseases and cancer
|
Mukund, Vidya
|
|
2017
|
119 |
C |
p. 13-22
10 p.
|
artikel
|
| 11 |
Hand-foot skin reaction with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis
|
Li, Jing
|
|
2017
|
119 |
C |
p. 50-58
9 p.
|
artikel
|
| 12 |
Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials
|
El Osta, B.
|
|
2017
|
119 |
C |
p. 1-12
12 p.
|
artikel
|
| 13 |
Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: Has it yet become state-of-the-art?
|
van der Weijst, Lotte
|
|
2017
|
119 |
C |
p. 40-49
10 p.
|
artikel
|
Tijdschrift beschrijving